Available Technologies
# of Displayed Technologies: 4 / 4
Applied Category Filter (Click To Remove): Genetic Disorders
An improved base editor (iABE-NG) for correcting genetic diseases such as Duchenne muscular dystrophy
TS-049505 — An engineered base editor (iABE-NG) that uses an SpCas9 variant, a shortened adenine deaminase domain with eliminated RNA off-target activity, and an intein split for packaging into an adeno-associated virus (AAV), resulting in gene mutation correction.
There are thousands of monogenic diseases that are lacking effective therapeutic treatments. The main bottleneck in developing effective treatment is the ability to effectively edit gene while controlling for the myriad of off-target effects that come with targeting the genome. Duchenne Muscular D…
- College: College of Medicine (COM)
- Inventors: Han, Renzhi; Gao, Yandi; Xu, Li
- Licensing Officer: Schworer, Adam
Multi-Functional Drug Delivery Nanodevice for Precision Medicine
TS-041485 — A functionalized DNA nanostructure made through a scaffolded DNA origami molecular self-assembly process to deliver clinically significant concentrations of therapeutics.
This novel therapeutic approach leverages structural nanotechnology to create a DNA nanostructure that acts as a customizable delivery vehicle for therapeutic molecules. The technology allows for a highly tunable and customizable multi-functional drug delivery platform that incorporates interchang…
- College: College of Engineering (COE)
- Inventors: Castro, Carlos; Byrd, John; Halley, Patrick; Lucas, Christopher
- Licensing Officer: He, Panqing
Sustained Release Microparticles for the Treatment of Ocular Diseases
TS-038312 — A novel, intravitreal microparticle injection capable of controlled-release of protein therapies (including anti-VEGF) for tunable periods of 6-12 months after injection for the treatment of age-related macular degeneration.
Age-related macular degeneration (AMD) is the leading cause of blindness in individuals 65 and older and is the third leading cause of blindness worldwide. Wet AMD is characterized by abnormal growth of leaky blood vessels leading to damage to the macula of the retina resulting in vision loss and …
- College: College of Engineering (COE)
- Inventors: Jiang, Pengfei; Ohr, Matthew; Reilly, Katelyn
- Licensing Officer: Schworer, Adam
Family HealthLink: A Health Risk Assessment Tool
TS-037825 — An online interactive tool that helps a patients and physicians assess a likelihood of cancer or heart disease, based on family history.
Physician documentation of family history in the EPIC® EMR for breast and ovarian cancer has been a common practice for many years, but documentation and assessment for other cancer types (and extended family history) have remained sparse and incomplete (Sweet, Sturm et al. 2015). In addition …
- College: College of Medicine (COM)
- Inventors: Sweet, Kevin; Newman, David "David"; Sturm, Amy; Westman, Judith "Judy"
- Licensing Officer: Taysavang, Panya
